Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H Rassekh

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|December 9, 2016
Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal PrimariesKyle M Hatten, Bert W O'Malley, Andres M Bur, et al.
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 8, 2021
Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomasHarman S Parhar, Gregory S Weinstein, Bert W O'Malley, et al.
OTO Open|August 26, 2020
Snapshot Impact of COVID-19 on Mental Wellness in Nonphysician Otolaryngology Health Care Workers: A National StudyAman Prasad, Alyssa M Civantos, Yasmeen Byrnes, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Oral Oncology|November 6, 2021
Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinomaJustin R Shinn, Ryan M Carey, Leila J Mady, et al.
Head & Neck|June 5, 2020
Mental health among otolaryngology resident and attending physicians during the COVID-19 pandemic: National studyAlyssa M Civantos, Yasmeen Byrnes, Changgee Chang, et al.
Head & Neck|June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgeryLova Sun, David Shimunov, Erik X Tan, et al.
Oral Oncology|March 4, 2022
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancersRobert M Brody, David Shimunov, Roger B Cohen, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
JAMA Otolaryngology-- Head & Neck Surgery|December 9, 2016
Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal PrimariesKyle M Hatten, Bert W O'Malley, Andres M Bur, et al.
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Head & Neck|June 8, 2021
Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomasHarman S Parhar, Gregory S Weinstein, Bert W O'Malley, et al.
OTO Open|August 26, 2020
Snapshot Impact of COVID-19 on Mental Wellness in Nonphysician Otolaryngology Health Care Workers: A National StudyAman Prasad, Alyssa M Civantos, Yasmeen Byrnes, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Oral Oncology|November 6, 2021
Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinomaJustin R Shinn, Ryan M Carey, Leila J Mady, et al.
Head & Neck|June 5, 2020
Mental health among otolaryngology resident and attending physicians during the COVID-19 pandemic: National studyAlyssa M Civantos, Yasmeen Byrnes, Changgee Chang, et al.
Head & Neck|June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgeryLova Sun, David Shimunov, Erik X Tan, et al.
Oral Oncology|March 4, 2022
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancersRobert M Brody, David Shimunov, Roger B Cohen, et al.
Pageof 9